Journal Article

A multi-stage genome-wide association in breast cancer identifies two novel risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

Fraumeni, Joseph F., Wacholder, Sholom, Willett, Walter C., Sigurdson, Alice, Vatten, Lars J, McCarty, Catherine A., Gonzalez-Bosquet, Jesus, Chlebowski, Rowan, Tucker, Margaret, Jackson, Rebecca, Lissowska, Jolanta, Doody, Michele, Prentice, Ross, Hutchinson, Amy, Hveem, Kristian, Feigelson, Heather Spencer, Hayes, Richard B., Thomas, Gilles, Colditz, Graham A., Diver, Ryan, Buring, Julie, Orr, Nick, Jacobs, Kevin B., Cox, David G., Lee, I-Min, Brinton, Louise A., Thun, Michael J., Kooperberg, Charles, Yeager, Meredith, Yu, Kai, Prokunina-Olsson, Ludmila, Buys, Saundra S., Gerhard, Daniela S., Alexander, Bruce H., Chatterjee, Nilanjan, Ziegler, Regina G., Chanock, Stephen J, Hunter, David J., Kraft, Peter, Peplonska, Beata, Bhatti, Parveen, Wang, Zhaoming, Calle, Eugenia E., Kumle, Merethe, Garcia-Closas, Montserrat, Hoover, Robert N., Hankinson, Susan E., Berg, Christine D.

2009

Overview

The Cancer Genetic Markers of Susceptibility (CGEMS) initiative has conducted a three-stage genome-wide association study (GWAS) of breast cancer in 9,770 cases and 10,799 controls. In Stage 1, we genotyped 528,173 single nucleotide polymorphisms (SNPs) in 1,145 cases of invasive breast cancer among postmenopausal white women, and 1,142 controls; in Stage 2, 24,909 SNPs with low p values observed in Stage 1 were analyzed in 4,547 cases and 4,434 controls. In Stage 3 we investigated 21 loci in 4,078 cases and 5,223 controls with low p values from Stage 1 and 2 combined. Two novel loci achieved genome-wide significance. A pericentromeric SNP on chromosome 1p11.2, rs11249433, (p=6.74 × 10-10 adjusted genotype test with 2 degrees of freedom) resides in a large block of linkage disequilibrium neighboring NOTCH2 and FCGR1B and is predominantly associated with estrogen receptor-positive breast cancer. A second SNP, rs999737 on chromosome 14q24.1 (p=1.74 × 10−7), localizes to RAD51L1, a gene in the homologous recombination DNA repair pathway, a prior candidate pathway for breast cancer susceptibility. We confirmed previously reported markers on chromosome 2q35, 5q11.2, 5p12, 8q24, 10q26, and 16q12.1. Our results underscore the importance of large-scale replication in the identification of low penetrance breast cancer alleles.